Diffusion Magnetic Resonance Imaging (dMRI) in the Early Evaluation of Brain White Matter Diseases
Recruiting
Observational Study
Diffusion Magnetic Resonance Imaging
Brain White Matter Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- The General Authority for Teaching Hospitals and Institutes · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To assess the sensitivity and accuracy of diffusion magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI) metrics, in identifying early-stage changes in brain white matter related to various white matter diseases.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18-80 years.
* Clinical suspicion of early-stage white matter disease.
* No prior diagnosis of significant neurological disorders (e.g., stroke, brain tumors).
* Ability to provide informed consent.
Exclusion Criteria:
* Pregnancy or breastfeeding.
* Contraindica…
Contacts